Methyl 2-Bromohexanoate (CAS NO : 5445-19-2)

Methyl 2-bromohexanoate (CAS No: 5445-19-2) functions as a sophisticated alpha-halogenated ester intermediate, increasingly pivotal for the precision synthesis of heterocyclic frameworks such as 2-butyl-2H-pyrido[3,2-b]-1,4-oxazin-3(4H)-one within the pharmaceutical sector. The compound's high reactivity, driven by the dual functionality of its bromine and ester groups, facilitates essential substitution, alkylation, and condensation reactions required for producing high-purity antihypertensive agents, anticonvulsants, and specialty agrochemical building blocks like pyrethroids and triazoles. As the global chemical market shifts toward high-performance specialty intermediates, Methyl 2-bromohexanoate is witnessing robust demand within the CDMO sector, particularly for advanced route scouting and the development of complex bioactive molecules that require stringent 98% purity levels to maintain regulatory compliance. As globally established Methyl 2-Bromohexanoate supplier with Methyl 2-Bromohexanoate purity 98%. We ensure dependable supply, consistent quality, and complete regulatory documentation, including Methyl 2-Bromohexanoate CoA and Methyl 2-Bromohexanoate TDS across all grades. Beyond supply, we support partners through the entire product lifecycle from route scouting, process and formulation development, and analytical method development to scale-up, process optimisation, and pilot-to-commercial manufacturing. Our teams also assist with GMP-compliant quality assurance, regulatory documentation, and global supply chain and logistics coordination.